Viewing Study NCT00648102


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-02-23 @ 3:18 PM
Study NCT ID: NCT00648102
Status: COMPLETED
Last Update Posted: 2010-07-26
First Post: 2008-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
Sponsor: Celldex Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Colorectal Cancer View
None Pancreatic Cancer View
None Bladder Cancer View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None Colorectal cancer View
None Pancreatic cancer View
None Bladder cancer View
None Ovarian cancer View
None Metastatic cancer View
None Locally advanced cancer View
None Cancer Vaccine View
None Vaccine View